Open NebulaBack to home
Back to Resources
November 9, 2026StocksTechnology·Bullish·clinical data

Hengrui, Braveheart report positive 52-week data for heart disease drug HRS/BHB-1893

Hengrui and Braveheart reported positive 52-week data for their heart disease drug HRS/BHB-1893.

Detected & updated continuously · Source: Nebula

Story subjects

HengruiBraveheart

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula